Literature DB >> 8717376

Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus.

P Naylor1, C A Stewart, S R Wright, R C Pearson, I C Reid.   

Abstract

The neural basis underlying the cognitive side effects of ECT is unknown. Recent studies suggest that the memory dysfunction may be caused by alterations in hippocampal synaptic efficacy [20]. In situ hybridisation was used to examine the possible receptor mechanisms responsible for this effect. Repeated ECS markedly increased mRNA expression for the GluR1 subunit of the AMPA receptor, but not the NMDAR1A-G subtypes of the NMDA receptor, relative to control treatments. This effect was present 24 h after the last seizure and may be responsible for the expression of the ECS-induced increase in synaptic efficacy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717376     DOI: 10.1016/0169-328x(95)00264-s

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

Review 1.  Brain plasticity and antidepressant treatments: new cells, new connections.

Authors:  Ian C Reid; Caroline A Stewart
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

Authors:  P A Boyer; P Skolnick; L H Fossom
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

3.  O brother, wherefore are thou? Calcium-permeable AMPA receptors make an appearance in adult status epilepticus.

Authors:  Tim Benke
Journal:  Epilepsy Curr       Date:  2013-01       Impact factor: 7.500

4.  Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.

Authors:  Vanja Duric; Mounira Banasr; Craig A Stockmeier; Arthur A Simen; Samuel S Newton; James C Overholser; George J Jurjus; Lesa Dieter; Ronald S Duman
Journal:  Int J Neuropsychopharmacol       Date:  2012-02-17       Impact factor: 5.176

Review 5.  Epilepsy as an example of neural plasticity.

Authors:  Helen E Scharfman
Journal:  Neuroscientist       Date:  2002-04       Impact factor: 7.519

Review 6.  An excitatory synapse hypothesis of depression.

Authors:  Scott M Thompson; Angy J Kallarackal; Mark D Kvarta; Adam M Van Dyke; Tara A LeGates; Xiang Cai
Journal:  Trends Neurosci       Date:  2015-04-14       Impact factor: 13.837

Review 7.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test.

Authors:  Todd D Gould; Kelley C O'Donnell; Eliot R Dow; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropharmacology       Date:  2007-11-17       Impact factor: 5.250

Review 9.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 10.  Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes.

Authors:  Vanja Duric; Ronald S Duman
Journal:  Cell Mol Life Sci       Date:  2012-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.